Date: April 5, 2022
Time: 6:30pm
Course Description
The lecture will present new information and understanding of newer anti-resorptive medications increasingly being used for treatment of osteoporosis and for prevention of skeletal related events such as metastasis in certain malignancies. These medications are increasingly associated with causing osteonecrosis of the jaws. The biological and pharmacological differences of these newer drugs like denosumab, avastin, etc will be compared and contrasted with bisphosphonates. Today’s dentist and oral health care provider should be aware of these newer medications and adjust or alter dental treatment based on new information.
Learning Objectives:
Upon completion of this course, participants should be able to:
• Recognize and understand the newer anti-resorptive medications
• Understand the implications of these drugs in dental practices.
• Understand the underlying pathogenesis, signs and symptoms of osteonecrosis.
• Recognize the differences these drugs have from bisphosphonates.
• Understand what modifications in dental treatment planning may be required when presented with patients taking newer antiresorptive medications.
About the Speaker:
Dr. Neel Bhattacharyya obtained oral and maxillofacial pathology training with a Master’s degree from the Indiana University School of Dentistry, Indianapolis. He received his DDS from the University of Nebraska College of Dentistry. He is a diplomate of the American Board of Oral and Maxillofacial Pathology. He is currently, a tenured Full Professor and the Director of the Laboratory and Division of Oral Pathology at the University of Florida College of Dentistry. He has been at UF for over 18 years and has won numerous teaching awards throughout his career including six at UF. He is actively involved in a clinical and microscopic oral pathology practice which he has contributed in building into one of the largest oral pathology biopsy services in the nation. Currently the UF Oral Pathology biopsy service accessions over 14000 tissue specimens. He has authored or co-authored more than 160 refereed papers and book chapters covering a diverse range of topics addressing both clinical and microscopic aspects of oral and maxillofacial pathology and oral biology. He is also actively involved in several NIH and industry funded research projects studying medication induced osteonecrosis of jaws, molecular and clinical aspects of oral and jaw lesions, precancerous and cancerous oral lesions, polymicrobial periodontal disease and systemic diseases in animal models and Sjogren’s syndrome. Dr. Bhattacharyya is a sought after speaker and has lectured extensively in the US and abroad at various regional, national and international meetings.
